Search

everythinglearnresearchcommunity

for

Search:↓

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

ADAM17 could be a potential target for treating PCOS.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 can cause hair loss, but specialists can help treat it.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Thyroid function may influence hair loss after COVID-19.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Lower LDL-c levels predict higher COVID-19 mortality.

Social media data can help track and predict COVID-19 symptoms and trends.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause different skin issues, including rashes and hair loss.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The model and estimator can predict drug exposure in kidney transplant patients well.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

No significant link between male pattern baldness and COVID-19 severity was found.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.